150 related articles for article (PubMed ID: 8758261)
21. Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines.
Hour TC; Chen J; Huang CY; Guan JY; Lu SH; Hsieh CY; Pu YS
Anticancer Res; 2000; 20(5A):3221-5. PubMed ID: 11062746
[TBL] [Abstract][Full Text] [Related]
22. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.
Mistry P; Kelland LR; Abel G; Sidhar S; Harrap KR
Br J Cancer; 1991 Aug; 64(2):215-20. PubMed ID: 1892748
[TBL] [Abstract][Full Text] [Related]
23. Xeroderma pigmentosum group a protein and chemotherapy resistance in human germ cell tumors.
Honecker F; Mayer F; Stoop H; Oosterhuis JW; Koch S; Bokemeyer C; Looijenga LH
Lab Invest; 2003 Oct; 83(10):1489-95. PubMed ID: 14563950
[TBL] [Abstract][Full Text] [Related]
24. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
[TBL] [Abstract][Full Text] [Related]
25. [A study on the relationship between sensitivity to CDDP and inducibility of metallothionein and glutathione of genitourinary tumors].
Yamagata K; Kondo Y
Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1575-82. PubMed ID: 7474609
[TBL] [Abstract][Full Text] [Related]
26. Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines.
Burger H; Nooter K; Boersma AW; Kortland CJ; Stoter G
Br J Cancer; 1998 May; 77(10):1562-7. PubMed ID: 9635829
[TBL] [Abstract][Full Text] [Related]
27. Relationships between resistance to cross-linking agents and glutathione metabolism, aldehyde dehydrogenase isozymes and adenovirus replication in human tumour cell lines.
Parsons PG; Lean J; Kable EP; Favier D; Khoo SK; Hurst T; Holmes RS; Bellet AJ
Biochem Pharmacol; 1990 Dec; 40(12):2641-9. PubMed ID: 2260988
[TBL] [Abstract][Full Text] [Related]
28. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
Lau DH; Lewis AD; Ehsan MN; Sikic BI
Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
[TBL] [Abstract][Full Text] [Related]
29. The role of metallothionein, glutathione, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agents.
Hrubisko M; McGown AT; Fox BW
Biochem Pharmacol; 1993 Jan; 45(1):253-6. PubMed ID: 8424817
[TBL] [Abstract][Full Text] [Related]
30. Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines?
Campling BG; Baer K; Baker HM; Lam YM; Cole SP
Br J Cancer; 1993 Aug; 68(2):327-35. PubMed ID: 8102244
[TBL] [Abstract][Full Text] [Related]
31. Hypersensitivity of human testis-tumour cell lines to chemotherapeutic drugs.
Masters JR; Osborne EJ; Walker MC; Parris CN
Int J Cancer; 1993 Jan; 53(2):340-6. PubMed ID: 8425772
[TBL] [Abstract][Full Text] [Related]
32. Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines.
Welters MJ; Fichtinger-Schepman AM; Baan RA; Flens MJ; Scheper RJ; Braakhuis BJ
Br J Cancer; 1998 Feb; 77(4):556-61. PubMed ID: 9484811
[TBL] [Abstract][Full Text] [Related]
33. Seladin-1 and testicular germ cell tumours: new insights into cisplatin responsiveness.
Nuti F; Luciani P; Marinari E; Erdei E; Bak M; Deledda C; Rosati F; Mazzinghi B; Danza G; Stoop H; Looijenga LH; Peri A; Serio M; Krausz C
J Pathol; 2009 Dec; 219(4):491-500. PubMed ID: 19844922
[TBL] [Abstract][Full Text] [Related]
34. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts.
Goddard P; Valenti M; Kelland LR
Anticancer Res; 1994; 14(3A):1065-70. PubMed ID: 8074451
[TBL] [Abstract][Full Text] [Related]
35. Insights into mechanisms of cisplatin resistance and potential for its clinical reversal.
Gosland M; Lum B; Schimmelpfennig J; Baker J; Doukas M
Pharmacotherapy; 1996; 16(1):16-39. PubMed ID: 8700790
[TBL] [Abstract][Full Text] [Related]
36. Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteins.
Eid H; Géczi L; Mágori A; Bodrogi I; Institoris E; Bak M
Anticancer Res; 1998; 18(4C):3059-64. PubMed ID: 9713510
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
38. Chemical modulation of chemotherapy resistance in cultured oesophageal carcinoma cells.
Sheehan D; Meade G
Biochem Soc Trans; 2000 Feb; 28(2):27-32. PubMed ID: 10816094
[TBL] [Abstract][Full Text] [Related]
39. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
Perry J; Powles T; Shamash J; Veerupillai A; McGrowder E; Noel E; Lu YJ; Oliver T; Joel S
Cancer Chemother Pharmacol; 2009 Oct; 64(5):925-33. PubMed ID: 19263053
[TBL] [Abstract][Full Text] [Related]
40. Determinants of drug response in a cisplatin-resistant human lung cancer cell line.
Fujiwara Y; Sugimoto Y; Kasahara K; Bungo M; Yamakido M; Tew KD; Saijo N
Jpn J Cancer Res; 1990 May; 81(5):527-35. PubMed ID: 2116401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
